Skip to main content
Loading

Likarda

February 27, 2024
Platform for Therapeutics
Likarda
Likarda has pioneered a groundbreaking platform for hydrogel delivery systems, offering both long- and short-term solutions that can either provide complete immuno-protection or degrade gradually. This innovation enables precise localized therapy delivery without the need for immunosuppression, effectively addressing critical gaps in cell therapy. Our CSS Platform significantly enhances therapy efficacy by targeting specific areas, reducing off-target effects, and minimizing the required cell numbers for a therapeutic dose. In essence, Likarda's innovative hydrogel platform revolutionizes cell therapy delivery, addressing challenges in storage, shipping, and targeted delivery while offering scalable, cost-effective solutions.
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP